Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interfering antiviral immunity: application, subversion, hope?

N Manjunath1, Priti Kumar, Sang Kyung Lee

  • 1The CBR Institute for Biomedical Research and Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.

Trends in Immunology
|June 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a recombinant adeno-associated virus vector for human T lymphocyte- and natural killer cell-targeted gene therapy.

bioRxiv : the preprint server for biology·2026
Same author

Laparoscopic Iliopubic Tract Repair for Acquired Pediatric Inguinal Hernia.

Journal of laparoendoscopic & advanced surgical techniques. Part A·2026
Same author

Advancing Iron Therapy in Maternal Health: Evolving Strategies for Treating Iron Deficiency Anemia.

Obstetrical & gynecological survey·2025
Same author

The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCC.

Nature communications·2025
Same author

Quantifying the morphological variations of internal carotid artery in moyamoya angiopathy.

British journal of neurosurgery·2025
Same author

Safety, pharmacokinetics, and biological activity of CD4-mimetic BNM-III-170 in SHIV-infected rhesus macaques.

Journal of virology·2025
Same journal

IL-33 scripts cancer immunity.

Trends in immunology·2026
Same journal

Mitochondrial Ca<sup>2+</sup> signaling: A metabolic rheostat defining tumor and immune cell fate.

Trends in immunology·2026
Same journal

Cross-priming underlies the efficacy of antibody-drug conjugates and immunotherapy combinations.

Trends in immunology·2026
Same journal

Gut microbiome metabolites meet immunometabolism in inflammatory bowel disease.

Trends in immunology·2026
Same journal

Metabolic regulatory nodes of the inflammasome and inflammatory cell death.

Trends in immunology·2026
Same journal

Parental leave in immunology - 6.

Trends in immunology·2026
See all related articles

RNA interference (RNAi) is a powerful gene-silencing tool with antiviral potential in mammals. Recent progress shows promise for treating viral infections, but challenges remain for clinical use.

Area of Science:

  • Molecular Biology
  • Virology
  • Genetics

Background:

  • RNA interference (RNAi) is a natural gene-silencing mechanism.
  • RNAi has been identified as a key antiviral defense in plants.
  • Its application has expanded to mammals for sequence-specific gene suppression.

Purpose of the Study:

  • To review recent advancements in RNAi technology for viral infections.
  • To assess the potential of RNAi as a therapeutic strategy.
  • To identify remaining challenges for clinical applications.

Main Methods:

  • Review of scientific literature from the past 2-3 years.
  • Analysis of in vitro and in vivo studies demonstrating RNAi efficacy.
  • Evaluation of preclinical models (mouse and monkey).

Related Experiment Videos

Main Results:

  • RNAi demonstrates significant potential to inhibit viral replication.
  • Successful demonstrations in various animal models.
  • Growing interest in RNAi for unmet medical needs in viral diseases.

Conclusions:

  • RNAi holds considerable promise as a novel antiviral therapy.
  • Further research is needed to overcome existing hurdles for clinical translation.
  • RNAi technology is rapidly advancing towards therapeutic applications.